StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3089% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie Botox Cosmetic (onabotulinumtoxinA) by Quarter

Botox Cosmetic (onabotulinumtoxinA) — U.S. net revenues ($M) ($M)

QuarterlyAnnual

AbbVie Botox Cosmetic (onabotulinumtoxinA): $400M in Q2 2026, down 2.4% from a year earlier.

Latest, Q2 2026
400
Period ended Jun 30, 2026
Change on a year earlier
-2.4%
410 in Q2 2025
History
29 quarters
Since Q2 2019
Sources
24
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-03) ↗

Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Key Product Revenues.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBotox Cosmetic (onabotulinumtoxinA) — U.S. net revenues ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026400-2.4%Form 10-Q (filed 2026-08-03) ↗
Q1 2026Mar 31, 2026371+25.8%Form 10-Q (filed 2026-05-08) ↗
Q4 2025Dec 31, 2025420-2.1%Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 2025379-8.5%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 2025410-8.9%Form 10-Q (filed 2026-08-03) ↗
Q1 2025Mar 31, 2025295-24.2%Form 10-Q (filed 2026-05-08) ↗
Q4 2024Dec 31, 2024429-5.3%Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 2024414+6.7%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 2024450+7.1%Form 10-Q (filed 2025-08-04) ↗
Q1 2024Mar 31, 2024389-4.9%Form 10-Q (filed 2025-05-09) ↗
Q4 2023Dec 31, 2023453+7.3%Form 10-K (filed 2026-02-20) ↗
Q3 2023Sep 30, 2023388+4.9%Form 10-Q (filed 2024-11-04) ↗
Q2 2023Jun 30, 2023420-6.5%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 2023409-1.0%Form 10-Q (filed 2024-05-03) ↗
Q4 2022Dec 31, 2022422+6.3%Form 10-K (filed 2025-02-14) ↗
Q3 2022Sep 30, 2022370+3.9%Form 10-Q (filed 2023-11-06) ↗

Breakdown

What makes up botox Cosmetic (onabotulinumtoxinA)

Cite this data

StockData. (2026). AbbVie Botox Cosmetic (onabotulinumtoxinA) ($M), quarterly Q2 2019–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/botox-cosm-us

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.